Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, today announced its new identity, Cellular Intelligence. This rebrand reflects the company's vision to ...

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

A study led by Maria Carmo-Fonseca at GIMM has helped clarify one of the main limitations of lab-grown heart cells, which are ...

Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...

PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...

One of the most well-studied cellular responses is how they react during times of stress, such as when the temperature gets ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

The constant, energy-driven motion inside living cells may generate electricity in a way no one fully recognized before.

Cells spend energy not just on reactions, but on control. New research explains why staying stable comes with an unseen ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.